Thursday, February 16, 2017 4:55:16 PM
WHY IT WENT UP TODAY:
Current Report Filing (8-k)
Date : 02/15/2017 @ 4:37PM
Source : Edgar (US Regulatory)
Stock : Proto Script Pharmaceutical Corp. (PC) (PSCR)
Quote : 0.12 0.06 (100.00%) @ 4:32PM
On February 7, 2017, Proto Script Pharmaceutical Corp. (the “Company”) and Michelle Rico (“Rico”), the Company’s sole officer and director, entered into a Share Exchange Agreement (the “Agreement”). Pursuant to the Agreement, Rico agreed to exchange 295,000,000 shares of common stock that she owns into 1,500,000 shares of Series A Preferred Stock. The Company will cancel the 295,000,000 shares of common stock and returned them back to treasury.
The shares of preferred stock to be issued pursuant to the Agreement, shall be issued in reliance upon an exemption from registration afforded under Section 4(a)(2) of the Securities Act for transactions by an issuer not involving a public offering, or Regulation D promulgated thereunder. The Agreement is an exempt transaction pursuant to Section 4(a)(2) of the Securities Act as the share exchange was a private transaction by the Company and did not involve any public offering.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM